Attached files
file | filename |
---|---|
8-K/A - VASO Corp | vaso8ka-sept42011.htm |
EX-99.2 - VASOMEDICAL UNAUDITED PROFORMA FINANCIALS - VASO Corp | vaso8kaproforma-ex992.htm |
EX-99.1.2 - PJM AUDITED FINANCIALS 12/31/10 - VASO Corp | vaso8ka-pjm2010ex9912.htm |
EX-99.1.1 - BIOX AUDITED FINANCIALS 12/31/10 - VASO Corp | vaso8ka-biox2010ex9911.htm |
EX-99.1.3 - BIOX UNAUDITED FINANCIALS 6/30/11 - VASO Corp | vaso8ka-biox2011ex9913.htm |
Life Enhancement Technology Ltd.
|
||||||||
Statement of Operations
|
||||||||
For the Six Months Ended June 30, 2011 and 2010
|
||||||||
ITEMS
|
SIX MONTHS ENDED JUNE 30, 2011
RMB
|
SIX MONTHS ENDED JUNE 30, 2010
RMB
|
||||||
Sales
|
2,637,222.72 | 581,517.04 | ||||||
Including: Export sales
|
||||||||
Less: Sales discounts and allowances
|
||||||||
Net sales
|
2,637,222.72 | 581,517.04 | ||||||
Less: Sales tax
|
40,264.95 | 219.77 | ||||||
Cost of sales
|
1,083,724.37 | 368,730.28 | ||||||
Including: Cost of export sales
|
||||||||
Gross profit on sales
|
1,513,233.40 | 212,566.99 | ||||||
Less: Selling expenses
|
60,563.40 | 18,376.94 | ||||||
General and administrative expenses
|
531,647.69 | 392,129.22 | ||||||
Financial expenses
|
31,777.12 | 6.84 | ||||||
Including : Interest expenses (less interest income)
|
30,462.12 | |||||||
Exchange loss (less exchange gains)
|
||||||||
Profit on sales
|
889,245.19 | (197,946.01 | ) | |||||
Add: Income from other operations
|
||||||||
Operating profit
|
889,245.19 | (197,946.01 | ) | |||||
Add: Investing gains
|
||||||||
Non-operating income
|
||||||||
Less: Non-operating expenses
|
- | |||||||
Add: Profit and loss adjustment for previous years
|
||||||||
TOTAL PROFIT
|
889,245.19 | (197,946.01 | ) | |||||
Less: Income tax
|
111,155.65 | |||||||
NET PROFIT
|
778,089.54 | (197,946.01 | ) | |||||
1
Life Enhancement Technology Ltd.
|
|||||||||
Balance Sheet
|
|||||||||
At June 30, 2011
|
|||||||||
ASSETS
|
Bal.E/P(RMB)
|
LIABILITIES AND OWNERS'EQUITY
|
Bal.E/P(RMB)
|
||||||
CURRENT ASSETS
|
CURRENT LIABILITIES
|
||||||||
Cash on hand
|
891.64 |
Short term loans
|
|||||||
Cash in bank
|
504,162.70 |
Notes payable
|
|||||||
Marketable securities
|
Accounts payable
|
239,737.01 | |||||||
Notes receivable
|
Accrued payroll
|
||||||||
Accounts receivable
|
Taxes payable
|
93,822.80 | |||||||
Less:Allowance for bad debts
|
Dividends payable
|
||||||||
Etrust bank to make collections
|
Advances received
|
24,013.60 | |||||||
Advances to suppliers
|
36,133.03 |
Other payables
|
1,228,381.27 | ||||||
Other receivables
|
448,806.52 |
Accured expenses
|
32,029.33 | ||||||
Prepaid and deferred expenses
|
Bonus and welfare funds for staff and workers
|
||||||||
Inventories
|
2,119,986.62 |
Long term liabilities payable at maturity within a year
|
|||||||
Less:Allowance for loss on realization of stock
|
|||||||||
Long term investment recovery due within a year
|
|||||||||
Other current assets
|
|||||||||
Total current assets
|
3,109,980.51 |
Total current liabilities
|
1,617,984.01 | ||||||
LONG TERM INVESTMENT
|
LONG TERM LIABILITIES
|
||||||||
Long term investment
|
Long term loans
|
||||||||
Receivables over a year
|
Bond payable
|
||||||||
FIXED ASSETS
|
Premium(discount) on bond payable
|
||||||||
Fixed assets-cost
|
577,729.99 |
Payable over a year
|
|||||||
Less:accumulated depreciation
|
515,720.27 |
OTHER LIABILITIES
|
|||||||
Fixed assets-net value
|
62,009.72 |
Exchange gain during preparation period
|
|||||||
Disposal of fixed assets
|
Deferred investment income
|
||||||||
CONSTRUCTION WORK IN PROCESS
|
Deferred lease income
|
||||||||
Construction work in process
|
Credit item of deferred tax
|
||||||||
INTANGIBLE ASSETS
|
Other deferred credits
|
||||||||
Right to the use of site
|
Exchange gain to be written off
|
||||||||
Industrial property and proprietary technology
|
1,617,984.01 | ||||||||
Other intangible assets
|
OWNER'S EQUITY
|
||||||||
Total intangible assets
|
|||||||||
OTHER ASSETS
|
Paid in capital
|
993,234.00 | |||||||
Organization expenses
|
Including: Foreign investment
|
993,234.00 | |||||||
Exchange loss during preparation period
|
|||||||||
Deferred investment losses
|
Translation reserve
|
||||||||
Debit item of deferred tax
|
Reserve fund
|
||||||||
Other deferred expenses
|
Expansion fund
|
||||||||
Exchange loss to be writton off
|
Repayment of investment by profit
|
||||||||
Current year profit
|
1,686,466.06 | ||||||||
Retained earnings
|
(1,125,693.84 | ) | |||||||
Total other assets
|
Total owners' equity
|
1,554,006.22 | |||||||
TOTAL ASSETS
|
3,171,990.23 |
TOTAL LIABILITIES AND OWNERS’ EQUITY
|
3,171,990.23 | ||||||
2